2010
DOI: 10.1172/jci39569
|View full text |Cite
|
Sign up to set email alerts
|

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome

Abstract: The glomerular basement membrane (GBM) is a key component of the filtering unit in the kidney. Mutations involving any of the collagen IV genes (COL4A3, COL4A4, and COL4A5) affect GBM assembly and cause Alport syndrome, a progressive hereditary kidney disease with no definitive therapy. Previously, we have demonstrated that the bone morphogenetic protein (BMP) antagonist uterine sensitization-associated gene-1 (USAG-1) negatively regulates the renoprotective action of BMP-7 in a mouse model of tubular injury d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
53
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 70 publications
(55 citation statements)
references
References 72 publications
(66 reference statements)
2
53
0
Order By: Relevance
“…Third, the crosstalk between tubules and the glomerulus could be postulated. 38,39 Glomerulosclerosis secondary to proximal tubule injuries is also observed in clinical situations. Mesoamerican nephropathy 40 represents interstitial fibrosis and glomerulosclerosis after repeated episodes of AKI.…”
Section: Discussionmentioning
confidence: 99%
“…Third, the crosstalk between tubules and the glomerulus could be postulated. 38,39 Glomerulosclerosis secondary to proximal tubule injuries is also observed in clinical situations. Mesoamerican nephropathy 40 represents interstitial fibrosis and glomerulosclerosis after repeated episodes of AKI.…”
Section: Discussionmentioning
confidence: 99%
“…PCOLCE2 protein modulates binding of procollagen C-proteases to collagen in a BMP1-dependent and celllineage-restricted manner (Steiglitz et al 2002), a process with significant relevance for the development and function of the glomerular basement membrane (Tanaka et al 2010). We investigated the disease-specific transcriptional regulation of PCOLCE2.…”
Section: Disease-specific Regulation Of the Nanodissection Gene Setsmentioning
confidence: 99%
“…A large number of therapeutic options to interfere with TGF-bioactivity has been tested in preclinical studies including antagonistic antibodies, soluble receptor forms, agents that inhibit downstream intracellular signaling molecules (in particular Smads), RNA interference and targeting of TGF--induced micro-RNAs (20,255,(257)(258)(259)(260). Other antifibrotic interventions in the system are focused on modulators of TGF-bioactivity, such as BMP-7 or BMP antagonists such as USAG-1 (253,261,262). BMP7 receptor Alk3 (263), and its downstream mediator Trps1 (264), have also been shown to be involved in kidney fibrosis.…”
Section: Key Molecular Effector Systems and Therapies In Renal Fibrosismentioning
confidence: 99%